Does benefit of weight-loss surgery for patients with diabetes persist over time?

January 16, 2018

Bottom Line: Obese adults with type 2 diabetes who underwent gastric bypass surgery continued to improve after five years at meeting a target for blood sugar, cholesterol and blood pressure control but that improvement seemed to lessen over time.

Why The Research Is Interesting: Reducing vascular and cardiovascular risks related to type 2 diabetes requires blood sugar control along with control of blood pressure and cholesterol. Roux-en-Y gastric bypass surgery is effective at achieving these diabetes treatment targets but whether the effects are long-lasting is unknown. The current study reports on longer-term outcomes for participants in a randomized clinical trial after five years.

Who and When: 120 obese adults with type 2 diabetes (half underwent Roux-en-Y gastric bypass surgery plus lifestyle and medical management interventions, the other half received lifestyle and medical management interventions alone); five-year follow up ended in 2016.

Study Measures: A composite measure of diabetes control: hemoglobin A1c less than 7.0 percent, low-density lipoprotein cholesterol less than 100 mg/dL, and systolic blood pressure less than 130 mm Hg after five years.

How (Study Design): Five year follow-up of patients randomized to Roux-en-Y gastric bypass surgery plus lifestyle and medical management interventions or lifestyle and medical management interventions alone.

Authors: Charles Billington, M.D., University of Minnesota, Minneapolis, and coauthors

Results: Patients who underwent gastric bypass surgery along with lifestyle and medical management interventions showed continued improvement at achieving a composite measure of diabetes control after five years but with some diminished effectiveness.

Study Limitations: Participants had diabetes for an average of nine years when they entered the study so the treatment effect on patients who had diabetes for a shorter time could be different.

Study Conclusions: While there was better achievement of diabetes control targets after five years, the effect was diminished over time so more follow-up is needed to understand if the improvement persists.
-end-
Related material:

The following related elements from this issue of JAMA are also available on the For The Media website:

-- Effect of Laparoscopic Sleeve Gastrectomy vs Laparoscopic Roux-en-Y Gastric Bypass on Weight Loss at 5 Years Among Patients With Morbid Obesity

-- Effect of Laparoscopic Sleeve Gastrectomy vs Laparoscopic Roux-en-Y Gastric Bypass on Weight Loss in Patients With Morbid Obesity

-- Association of Bariatric Surgery Using Laparoscopic Banding, Roux-en-Y Gastric Bypass, or Laparoscopic Sleeve Gastrectomy vs Usual Care Obesity Management With All-Cause Mortality

-- Association of Bariatric Surgery vs Medical Obesity Treatment With Long-term Medical Complications and Obesity-Related Comorbidities

-- Editorial: Comparing the Outcomes of Sleeve Gastrectomy and Roux-en-Y Gastric Bypass for Severe Obesity

-- Editorial: Reimagining Obesity in 2018 - A JAMA Theme Issue on Obesity

For more details and to read the full study, please visit the For The Media website.

(doi:10.1001/jama.2017.20813)

Editor's Note: Please see the article for additional information, including other authors, author contributions and affiliations, financial disclosures, funding and support, etc.

Want to embed a link to this report in your story? Link will be live at the embargo time http://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2017.20813

JAMA

Related Diabetes Articles from Brightsurf:

New diabetes medication reduced heart event risk in those with diabetes and kidney disease
Sotagliflozin - a type of medication known as an SGLT2 inhibitor primarily prescribed for Type 2 diabetes - reduces the risk of adverse cardiovascular events for patients with diabetes and kidney disease.

Diabetes drug boosts survival in patients with type 2 diabetes and COVID-19 pneumonia
Sitagliptin, a drug to lower blood sugar in type 2 diabetes, also improves survival in diabetic patients hospitalized with COVID-19, suggests a multicenter observational study in Italy.

Making sense of diabetes
Throughout her 38-year nursing career, Laurel Despins has progressed from a bedside nurse to a clinical nurse specialist and has worked in medical, surgical and cardiac intensive care units.

Helping teens with type 1 diabetes improve diabetes control with MyDiaText
Adolescence is a difficult period of development, made more complex for those with Type 1 diabetes mellitus (T1DM).

Diabetes-in-a-dish model uncovers new insights into the cause of type 2 diabetes
Researchers have developed a novel 'disease-in-a-dish' model to study the basic molecular factors that lead to the development of type 2 diabetes, uncovering the potential existence of major signaling defects both inside and outside of the classical insulin signaling cascade, and providing new perspectives on the mechanisms behind insulin resistance in type 2 diabetes and possibly opportunities for the development of novel therapeutics for the disease.

Tele-diabetes to manage new-onset diabetes during COVID-19 pandemic
Two new case studies highlight the use of tele-diabetes to manage new-onset type 1 diabetes in an adult and an infant during the COVID-19 pandemic.

Genetic profile may predict type 2 diabetes risk among women with gestational diabetes
Women who go on to develop type 2 diabetes after having gestational, or pregnancy-related, diabetes are more likely to have particular genetic profiles, suggests an analysis by researchers at the National Institutes of Health and other institutions.

Maternal gestational diabetes linked to diabetes in children
Children and youth of mothers who had gestational diabetes during pregnancy are at increased risk of diabetes themselves, according to new research published in CMAJ (Canadian Medical Association Journal).

Two diabetes medications don't slow progression of type 2 diabetes in youth
In youth with impaired glucose tolerance or recent-onset type 2 diabetes, neither initial treatment with long-acting insulin followed by the drug metformin, nor metformin alone preserved the body's ability to make insulin, according to results published online June 25 in Diabetes Care.

People with diabetes visit the dentist less frequently despite link between diabetes, oral health
Adults with diabetes are less likely to visit the dentist than people with prediabetes or without diabetes, finds a new study led by researchers at NYU Rory Meyers College of Nursing and East Carolina University's Brody School of Medicine.

Read More: Diabetes News and Diabetes Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.